DRUG · Mapped RxNorm record
Copaxone
Normalized identity: CopaxoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
NCT00937157
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedComparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Multiple Sclerosisverified · MONDO: multiple sclerosis
Interventions
CopaxoneDRUG · verified · RxNorm: Copaxone
Sponsors & collaborators
University at Buffalolead sponsor
Teva Neuroscience, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00937157 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.